1346456-01-6

Basic information

• Product Name: (5-(2-cyanophenmethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-yl) acetate
• Synonyms: (5-(2-cyanophenmethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-yl) acetate
• CAS NO: 1346456-01-6
• Molecular Weight: 312.392
• Mol File: 1346456-01-6.mol
• Article Data: 11

Chemical Properties

• CAS DataBase Reference: (5-(2-cyanophenmethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-yl) acetate(CAS DataBase Reference)
• NIST Chemistry Reference: (5-(2-cyanophenmethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-yl) acetate(1346456-01-6)
• EPA Substance Registry System: (5-(2-cyanophenmethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-yl) acetate(1346456-01-6)

Safety Data

• Hazardous Substances Data: 1346456-01-6(Hazardous Substances Data)

Upstream product

• 108-24-7 acetic anhydride 
• 109904-37-2 5,6,7,7a-tetrahydrothieno[3,2-c]pyridine-2(4H)-one monohydrochloride 
• 22115-41-9 2-(bromomethyl)benzonitrile 
• 115473-15-9 5,6,7,7a-tetrahydro-thieno[3,2-c]pyridin-2(4H)-one hydrochloride 

Downstream Products

• 1346456-05-0 (5-(2-cyanobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl)acetate hydrochloride 

Relevant articles and documents

Crystal form IX of Tipidogrel free alkali and preparation method and application thereof

The invention belongs to the technical field of medicine and particularly provides a crystal form IX of (5-(2-cyanobenzy)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-yl)acetate.The invention further provides a preparation method of the crystal form and application of the crystal form in preparation of anti-platelet aggregation pharmaceutical compositions.(Please see the chemical formula in the description.).

Crystal form VII of (5-2(2-cyanobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-yl)acetate and preparation method and application thereof

The invention belongs to the technical field of medicine and particularly provides a following crystal form VII of (5-2(2-cyanobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-yl)acetate. The invention further provides a preparation method of the above-mentioned crystal form and application of the crystal form in the preparation of pharmaceutical compositions for resisting platelet aggregation.

Crystal form X of Tipidogrel free alkali and preparation method and application thereof

The invention belongs to the technical field of medicine and particularly provides a crystal form X of (5-(2-cyanobenzy)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-yl)acetate.The invention further provides a preparation method of the crystal form and application of the crystal form in preparation of anti-platelet aggregation pharmaceutical compositions.(Please see the chemical formula in the description.).